Promise and challenges for direct small molecule AMPK activators

Biochem Pharmacol. 2018 Jul:153:147-158. doi: 10.1016/j.bcp.2018.01.049. Epub 2018 Feb 3.

Abstract

AMP-activated protein kinase (AMPK) is an evolutionary conserved and ubiquitously expressed serine/threonine kinase playing a central role in the coordination of energy homeostasis. Based on the beneficial outcomes of its activation on metabolism, AMPK has emerged as an attractive target for the treatment of metabolic diseases. Identification of novel downstream targets of AMPK beyond the regulation of energy metabolism has renewed considerable attention in exploiting AMPK signaling for novel therapeutic targeting strategies including treatment of cancer and inflammatory diseases. The complexity of AMPK system with tissue- and species-specific expression of multiple isoform combination regulated by various inputs, post-traductional modifications and subcellular locations presents unique challenges for drug discovery. Here, we review the most recent advances in the understanding of the mechanism(s) of action of direct small molecule AMPK activators and the potential therapeutic opportunities.

Keywords: AMPK; Drug discovery; Energy metabolism; Small molecule activator; Therapeutics.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • AMP-Activated Protein Kinases / metabolism*
  • Animals
  • Enzyme Activators / chemistry
  • Enzyme Activators / metabolism*
  • Enzyme Activators / therapeutic use
  • Humans
  • Metabolic Diseases / drug therapy
  • Metabolic Diseases / enzymology
  • Neoplasms / drug therapy
  • Neoplasms / enzymology
  • Protein Structure, Secondary
  • Signal Transduction / drug effects
  • Signal Transduction / physiology*

Substances

  • Enzyme Activators
  • AMP-Activated Protein Kinases